These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12000612)

  • 21. Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria.
    Russell AD
    Symp Ser Soc Appl Microbiol; 2002; (31):121S-135S. PubMed ID: 12481837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
    Rybak MJ
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gram-positive bacterial resistance. A challenge for the next millennium.
    Bassetti M; Melica G; Cenderello G; Rosso R; Di Biagio A; Bassetti D
    Panminerva Med; 2002 Sep; 44(3):179-84. PubMed ID: 12094131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanding the bactericidal action of the food color additive phloxine B to gram-negative bacteria.
    Rasooly R
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):239-44. PubMed ID: 15949926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efflux-mediated antibiotics resistance in bacteria].
    Cattoir V
    Pathol Biol (Paris); 2004 Dec; 52(10):607-16. PubMed ID: 15596311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains.
    Lockwood NA; Haseman JR; Tirrell MV; Mayo KH
    Biochem J; 2004 Feb; 378(Pt 1):93-103. PubMed ID: 14609430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin resistance in Staphylococcus aureus.
    Appelbaum PC; Bozdogan B
    Clin Lab Med; 2004 Jun; 24(2):381-402. PubMed ID: 15177846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT; Li Y; Wang J;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance.
    Gootz TD
    Biochem Pharmacol; 2006 Mar; 71(7):1073-84. PubMed ID: 16359640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens.
    Das B; Sarkar C; Biswas R; Pandey S
    Pak J Pharm Sci; 2008 Jan; 21(1):78-87. PubMed ID: 18166524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides.
    Epand RF; Mowery BP; Lee SE; Stahl SS; Lehrer RI; Gellman SH; Epand RM
    J Mol Biol; 2008 May; 379(1):38-50. PubMed ID: 18440552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are gram-positive bacteria capable of electron transfer across their cell wall without an externally available electron shuttle?
    Ehrlich HL
    Geobiology; 2008 Jun; 6(3):220-4. PubMed ID: 18498525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of isolation of common gram positive bacterial pathogens and their susceptibilities to antimicrobial agents in Jimma Hospital.
    Gebreselassie S
    Ethiop Med J; 2002 Apr; 40(2):115-27. PubMed ID: 12240573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outer Membrane Permeability of Cyanobacterium Synechocystis sp. Strain PCC 6803: Studies of Passive Diffusion of Small Organic Nutrients Reveal the Absence of Classical Porins and Intrinsically Low Permeability.
    Kowata H; Tochigi S; Takahashi H; Kojima S
    J Bacteriol; 2017 Oct; 199(19):. PubMed ID: 28696278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The outer parts of the mycobacterial envelope as permeability barriers.
    Draper P
    Front Biosci; 1998 Dec; 3():D1253-61. PubMed ID: 9851911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Permeability barrier of bacterial cell envelopes as cause of resistance to antibiotics (author's transl)].
    Fischer E; Braun V
    Immun Infekt; 1981; 9(3):78-87. PubMed ID: 7019046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterial porins--new channel proteins in unique outer membranes.
    Niederweis M
    Mol Microbiol; 2003 Sep; 49(5):1167-77. PubMed ID: 12940978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.